33 reports of this reaction
3.2% of all CALCIUM SULFATE ANHYDROUS reports
#2 most reported adverse reaction
PAIN is the #2 most commonly reported adverse reaction for CALCIUM SULFATE ANHYDROUS, manufactured by DNA Labs, Inc.. There are 33 FDA adverse event reports linking CALCIUM SULFATE ANHYDROUS to PAIN. This represents approximately 3.2% of all 1,039 adverse event reports for this drug.
Patients taking CALCIUM SULFATE ANHYDROUS who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is moderately reported among CALCIUM SULFATE ANHYDROUS users, representing a notable but not dominant share of adverse events.
In addition to pain, the following adverse reactions have been reported for CALCIUM SULFATE ANHYDROUS:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 33 FDA reports for CALCIUM SULFATE ANHYDROUS. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 3.2% of all adverse event reports for CALCIUM SULFATE ANHYDROUS, making it one of the most commonly reported side effect.
If you experience pain while taking CALCIUM SULFATE ANHYDROUS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.